Rel-(2R,3R,5S)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide

Catalog No. :
ACGLZG476
CAS No. :
1246733-29-8
Molecular Formula :
C10H12N4O5S
Molecular Weight :
300.05

IUPAC Name:Rel-(2R,3R,5S)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide

Rel-(2R,3R,5S)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$372.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-(2R,3R,5S)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
IUPAC NameRel-(2R,3R,5S)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
MDL No.MFCD00867002
Molecular FormulaC10H12N4O5S
Molecular Weight300.05
SMILESC[C@]1([C@H](N2[C@@](CC2=O)([H])S1(=O)=O)C(O)=O)CN3C=CN=N3
InChI KeyLPQZKKCYTLCDGQ-QXFUBDJGSA-N
Synonymrel-(2R,3R,5S)-3-((1H-1,2,3-Triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2R,3R,5S)-rel-
CAS No.1246733-29-8

Synthetic Route by SureRoute

1. ACGLZG476 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGLZG476 route product structure diagram
    ACGLZG4761246733-29-8
Inquiry

2. ACGLZG476 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGLZG476 route product structure diagram
    ACGLZG4761246733-29-8
Inquiry

Comments (0)